Skip to content
10-Q

Quarterly Report

Rich Pharmaceuticals, Inc.

0001662252-17-000254

← back to feed
Filed
Dec 29, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Dec 29, 2017 955.03M sh
Operating Cash Flow Q2 2018 · Sep 30, 2017 −$293.89K
Operating Cash Flow Q2 2018 · Sep 30, 2016 −$190.44K
Short Term Debt Q2 2018 · Sep 30, 2017 $920K
Short Term Debt Q2 2018 · Mar 31, 2017 $920K
Cash And Equivalents Q2 2018 · Sep 30, 2017 $24.97K
Cash And Equivalents Q2 2018 · Mar 31, 2017 $40.9K
Stockholders Equity Q2 2018 · Sep 30, 2017 −$5.31M
Stockholders Equity Q2 2018 · Mar 31, 2017 −$5.33M
Current Liabilities Q2 2018 · Sep 30, 2017 $5.36M
Current Liabilities Q2 2018 · Mar 31, 2017 $5.38M
Total Liabilities Q2 2018 · Sep 30, 2017 $5.36M
Total Liabilities Q2 2018 · Mar 31, 2017 $5.38M
Current Assets Q2 2018 · Sep 30, 2017 $40.27K
Current Assets Q2 2018 · Mar 31, 2017 $50.9K
Total Assets Q2 2018 · Sep 30, 2017 $56.81K
Total Assets Q2 2018 · Mar 31, 2017 $53.03K
Rd Expense Q2 2018 · Sep 30, 2017 $833
Rd Expense Q2 2018 · Sep 30, 2017 $148.41K
Net Income Q2 2018 · Sep 30, 2017 $1.8M
Net Income Q2 2018 · Sep 30, 2017 −$505.64K
Net Income Q2 2018 · Sep 30, 2016 −$266.52K
Net Income Q2 2018 · Sep 30, 2016 −$444.88K
Operating Income Q2 2018 · Sep 30, 2017 −$216.46K
Operating Income Q2 2018 · Sep 30, 2017 −$687.94K
Operating Income Q2 2018 · Sep 30, 2016 −$182.8K
Operating Income Q2 2018 · Sep 30, 2016 −$398.27K
Revenue Q2 2018 · Sep 30, 2017 $115K
Revenue Q2 2018 · Sep 30, 2017 $115K